Junichi Hara

Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 Mutations

Éric Bouffet, Jordan R. Hansford, Maria Luisa Garrè et al. · New England Journal of Medicine · 2023 · 266 citations

Medicine, Oncology, Pharmacotherapy +17

Primary analysis of a phase II trial of dabrafenib plus trametinib (dab + tram) in <i>BRAF</i> V600–mutant pediatric low-grade glioma (pLGG).

Éric Bouffet, Jordan R. Hansford, Maria Luisa Garrè et al. · Journal of Clinical Oncology · 2022 · 49 citations

Medicine, Oncology, Pharmacology +17

Dabrafenib + trametinib (dab + tram) in relapsed/refractory (r/r) <i>BRAF</i> V600–mutant pediatric high-grade glioma (pHGG): Primary analysis of a phase II trial.

Darren Hargrave, Keita Terashima, Junichi Hara et al. · Journal of Clinical Oncology · 2022 · 14 citations

Medicine, Oncology, Pediatrics +16